Effect of maleimide derivative on the morpho-functional state of the kidney in experimental colon carcinogenesis in rats
Kharchuk IV, Filins'ka OM, Iablons'ka SV, Rybal'chenko VK
Kyiv National Shevchenko University, Ukraine
DOI: https://doi.org/10.15407/fz56.06.062
Abstract
The effect of long-term administration of the novel maleimide derivative with antiproliferative activity on kidney morpho-functional state in experimental (1,2-dimethylhydrazine-in-duced) colon carcinogenesis has been investigated on 60 male rats. 1,2-Dimethylhydrazine was injected subcutaneously in dose 20 mg/kg one time per week during 20 weeks. Maleimide derivative in dose of 0,027 and 2,7 mg/kg was given per os daily during the same time. The state of kidneys was evaluated after morphometrical investigation and measurement of urea, creatinine and chlorides levels in blood serum. It hasn’t been revealed significant structure-functional changes in kidneys after daily administration during 20 weeks. The induction of proliferate activity of distal tubules epithelial cells and reducing of epithelial layer thickness in proximal tubules in kidneys in rats with experimental carcinogenesis has been observed. In experimental colon carcinogenesis, maleimide derivative displays some protective action to tubular apparatus of rat’s kidney cortical nephrons and reduces the frequency of preneoplastic changes in tubules epithelial cells.
Keywords:
maleimide derivatives, kidneys morpho-functional state, colon carcinogenesis.
References
- Dubinina G.G., Golovach SM., Kozlovs'kii V.O., Tolmachov A.O., Volovenko Yu.M. Antiprolife-rativna diya novih pohidnih 1-(4-R-benzil)-3-R1-4- (R2-fenilamino)-1H-pirol-2,5-dionu . Zhurn. org. ta farmatsevt. himii. 2007. Vin. 5, N 1. S 39-49.
- Zimina L.N., Galkina G.S. Lekarstvennaya gepatonef-ropatiya . Arh. patologii. 1988. 50, vip. 5. S. 58-65.
- Linchak O.V., Harchuk I.V., Karpezo N.O. Ostrovs'ka G.V., Ribal'chenko V.K. Stan slizovoi obolonki tonkoi kishki shchuriv pislya vplivu pohidnogo maleimidu . Zbir. nauk. prats' «Problemi ekologichnoi ta medichnoi genetiki i klinichnoi imunologii». K. Lugans'k-Harkiv. 2009. Vin. 8 (95). S 52-58.
- Linchak O.V., Harchuk I.V., Ostrovs'ka G.V., Karpezo I.O., Ribal'chenko V.K. Doslidzhennya vplivu pohidnogo maleimidu 1-(4-Cl-benzil)-3-hlor-4-(CF fenilamino)-Sh-pirol-2,5-dionu na morfologichnii stan pechinki . Zbir. nauk. prats' «Problemi ekologichnoi ta medichnoi genetiki i klinichnoi imunologii». K.-Lugans'k-Harkiv. 2007.- Vin. 3-4 (78-79). S 34-39.
- Ostrovs'ka G.V., Nizheradze K.O., Dubinina G.G., Ribal'chenko V.K. Tsitostatichna diya pohidnih maleimidu na klitinah linii NEK293 . 2-i z'izd Ukrains'kogo tovaristva klitinnoi biologii: Zbirnik tez (23-26 zhovtnya 2007r.). K., 2007. S 126.
- Harchuk I.V., Karpezo I.O., Ostrovs'ka G.V., Ribal'chenko T.V., Linchak O.V., Tsivins'ka SM., Ribal'chenko V.K. Morfofunktsional'ni zmini v sim'yanikah shchuriv pid vplivom novogo antineo-plastichnogo preparatu, pohidnogo maleimidu . Sovr. problemi toksikologii. 2008. N 1. S.61-65.
- Harchuk I.V., Karpezo I.O., Ostrovs'ka G.V., Ribal'chenko T.V., Ribal'chenko V.K. Osoblivosti morfofunktsional'nogo stanu nirok pid vplivom riznih doz ta trivalosti dii potentsiinogo tsitostatika pohidnogo maleimidu 1-(4-Cl-benzil)-3-Cl-4-(CF fenilamino)-1N-pirol-2,5-dionu . Dop. NAN Ukraini. 2009. N 10. S 185-188.
- Harchuk I.V., Karpezo N.O., Filins'ka O.M., Yablons'ka SV., Linchak O.V., Ribal'chenko V.K. Znizhennya nefrotoksichnogo vplivu oksidativnogo stresu pohidnim maleimidu 1-(4-Cl-benzil)-3-Cl-4-(CF-fenilamino)-Sh-pirol-2,5-dionom . Urologiya. 2009. N 1. S 27-31.
- Blume-Jensen P, Hunter T. Oncogenic kinase signaling . . Nature. 2001. 411. P. 355-365.
CrossRef
PubMed
- Dubinina G.G., Chupryna O.O., Platonov M.O., Borisko P.O., Ostrovska G.V., Tolmachov A.O., Shtil A.A. In Silico Design of Protein Kinase Inhibitors: Successes and Failures . Anti-Cancer Agents in Med. Chemistry. 2007. 7, N 2. P.171-188.
CrossRef
PubMed
- Kim JA. Targeted therapies for the treatment of cancer. . Amer. J. Surg. 2003. 86, N 3. P. 264-268.
CrossRef
- Lynchak O., Ostrovska G., Rybalchenko V. Effects of new maleimide derivate on the 1,2-dimethylhydrazine-induced colon carcinogenesis in rats . Gut "GASTRO 2009 UEGW. WCOG, London". 2009. 58 (Suppl. II). P.A334.
- Perse M., Cerar A. The dimethylhydrazine induced colorectal tumours in rat experimental colorectal carcinogenesis . Radiol. Oncol. 2005. 39, N 1. 61-70.
- Sathornsumetee S., Reardon D.A., Desjardins A., Quinn J.A., Vredenburgh J.J., Rich J.N. Molecularly targeted therapy for malignant glioma . Cancer. 2007 110, N 1. P.13-24.
CrossRef
PubMed
- Thaimattam R, Banerjee R, Miglani R, Iqbal J. Protein kinase inhibitors: structural insights into selectivity. Curr. Pharm. Des. 2007. 13, N 27. P. 2751-2765.
CrossRef
PubMed
- Toth B., Malick L., Shimizu H. Production of intestinal and other tumors by 1,2-dimethylhydrazine dihydro-chloride in mice. I. A light and transmission electron microscopic study of colonic neoplasms . Amer. J. Pathol. 1976. 84. P. 69-86.
- Turusov V.S., Chemeris G.Yu. Renal Cell Tumors Induced in CBA Male Mice by 1,2-Dimethylhydrazine . . Toxicol. Pathol. 1992. 20, N .4. P. 570-575.
CrossRef
PubMed
- Yablonska S., Filinska O., Ostrovska G., Linchack O., Dubinina G., Nizheradze K., Rybalchenko V. Antipro-liferative properties and low hepatotoxicity of new cytostatic maleimide derivate . The FEBS Journal "Biochemistry of cell regulation: 33rd FEBS Congress and 11th IUBMB Conference". 2008. 275. P.348.
- Yablonska S., Lynchak O., Filinska O., Ostrovska G., Shkira N., Kharchuk I., Nizheradze K., Rybalchenko V. Antiproliferative effects and influence on liver condition after per os administration of novel cytostatic maleimide derivate . The FEBS Journal "Life's molecular interactions: 34th FEBS Congress". 2009. 276. P.352.
|